yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q52563633-9B05819A-928E-4748-9FBE-DCD8A6CF4658
Q52563633-9B05819A-928E-4748-9FBE-DCD8A6CF4658
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52563633-9B05819A-928E-4748-9FBE-DCD8A6CF4658
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.
P2860
Q52563633-9B05819A-928E-4748-9FBE-DCD8A6CF4658
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52563633-9B05819A-928E-4748-9FBE-DCD8A6CF4658
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11071d5c15709f62a0aa46ac658b29f6e36ed0ac
P2860
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts